找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Kidney Cancer; Principles and Pract Primo N. Lara,Eric Jonasch Book 2015Latest edition The Editor(s) (if applicable) and The Author(s), und

[復制鏈接]
樓主: JAR
41#
發(fā)表于 2025-3-28 16:17:16 | 只看該作者
42#
發(fā)表于 2025-3-28 19:57:55 | 只看該作者
43#
發(fā)表于 2025-3-28 23:48:55 | 只看該作者
Biomarkers for Renal Cell Carcinomaf cancer. In contrast, biomarkers are helpful as more objective and reliable factors, which can either supplement or replace these largely subjective measures. Biomarkers can potentially play important roles in clinical research by clarifying measurable endpoints, which may lead to significant decre
44#
發(fā)表于 2025-3-29 06:58:02 | 只看該作者
45#
發(fā)表于 2025-3-29 10:28:56 | 只看該作者
46#
發(fā)表于 2025-3-29 14:46:21 | 只看該作者
47#
發(fā)表于 2025-3-29 19:03:27 | 只看該作者
Cytoreductive Nephrectomyry. This chapter will highlight the historical evolution of CN in the treatment of metastatic RCC, review the data regarding optimal patient selection, highlight the risks of CN, and explore future methods on how to better integrate surgery into the treatment of patients with metastatic RCC.
48#
發(fā)表于 2025-3-29 21:39:56 | 只看該作者
49#
發(fā)表于 2025-3-30 01:24:28 | 只看該作者
The Role of Radiation Therapy in Renal Cell Carcinomatment of RCC and conclude that RT does not have a major role in the management of localized RCC in the adjuvant setting but is effective for palliation and local control of distant sites of metastasis to the bone and brain in particular.
50#
發(fā)表于 2025-3-30 06:01:53 | 只看該作者
Adjuvant Systemic Therapy for Renal Cell Carcinomand have changed management of this stage of the disease. Many of these agents are currently being investigated in placebo-controlled adjuvant studies. While results of most of these trials are still awaited, there is optimism that these agents may prove effective and change the paradigm for the trea
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-9 04:58
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
扶余县| 西充县| 长武县| 融水| 瓦房店市| 洪江市| 龙口市| 潢川县| 根河市| 汉沽区| 湾仔区| 迁安市| 盐山县| 崇礼县| 嘉祥县| 延吉市| 张家口市| 浮梁县| 高雄县| 米易县| 萍乡市| 勃利县| 东至县| 青岛市| 本溪| 朔州市| 宁强县| 丹寨县| 浦北县| 贺州市| 武邑县| 台山市| 渑池县| 都匀市| 阜康市| 自治县| 腾冲县| 手游| 大悟县| 上饶县| 明溪县|